CGRP antagonists and dietary changes show promise for migraine treatment

Researchers reviewed recent advancements in migraine therapy, specifically the classification of the disease and clinical and diet intervention advancements aimed at significantly reducing the frequency, pain, and severity of attacks. They found that CGRP receptor antagonists and monoclonal antibodies, along with dietary and physical activity modifications, can substantially increase the number of migraine-free monthly days for patients. The study also highlighted the influence of food as either triggers or cures against migraines, with the Mediterranean and ketogenic diets being identified as safe and efficient interventions that can improve patients’ quality of life and, in some cases, halt migraines altogether.

Source link

error: Content is protected !!